Abstract
Purpose: To determine the safety, pharmacokinetics, and recommended phase II dose of an antibody-drug conjugate (ADC) targeting ectonucleotide phospho......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
